Jane Street’s abrdn Life Sciences Investors HQL Stock Holding History

Jane Street’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$366K	Buy	18,290 +3,353	+22%	+$59.3K	﹤0.01%	8750
2026 Q1	$243K	Sell	14,937 -1,699	-10%	-$28.4K	﹤0.01%	9693
2025 Q4	$279K	Buy	16,636 +2,665	+19%	+$44.8K	﹤0.01%	9001
2025 Q3	$217K	Buy	+13,971	New	+$191K	﹤0.01%	9524
2025 Q1	–	Sell	-22,098	Closed	-$290K	–	9902
2024 Q4	$290K	Buy	+22,098	New	+$319K	﹤0.01%	7787

Other funds holding HQL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Jane Street's HQL Position: Q2 2026 in Review

Jane Street increased its abrdn Life Sciences Investors (HQL) stake by 22% in Q2 2026, buying an estimated $59.3K and bringing the position to 18,290 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #8750.

Jane Street first reported a position in HQL in Q4 2024 and has held it in 5 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

Jane Street held 18,290 shares of abrdn Life Sciences Investors worth $366K as of Q2 2026.
Jane Street bought 3,353 abrdn Life Sciences Investors shares in Q2 2026, an estimated $59.3K.
abrdn Life Sciences Investors made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8750 holding.
Jane Street first reported a position in abrdn Life Sciences Investors in Q4 2024 and has held it in 5 quarters since.
83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.